Mast cell (MC) precursors migrate from the bone marrow as CD34
1 cells and complete their differentiation in peripheral tissues, such as dermal, mucosal, and perivascular sites, where they are poised to respond rapidly to danger signals. The ability of MCs to directly modulate efferent responses of T cells has been demonstrated in mice, whereby MCs are required to suppress graft-versus-host disease, 1 skin allograft rejection, 2, 3 and full expression of T cell-dependent arthritis. 4 Whether MCs can also modulate afferent immunity by acting as antigen-presenting cells (APCs) is controversial. [5] [6] [7] [8] [9] Defining characteristics of professional APCs include the ability to internalize soluble and particulate antigens, process and load antigen peptides onto MHC class II, translocate MHC-peptide complexes to the cell surface and express CD80/CD86, respond to local signals through pattern recognition receptors, migrate to draining lymph nodes, and activate both naive and memory CD4 1 T cells. 10 Although MCs have not been implicated as APCs in primary immune responses, their capacity to participate as APCs in a secondary immune response or in a superantigen-mediated response has been reported. In one study CD34
1 -derived IFN-g-stimulated MCs primed with bulk antigens (tetanus toxoid, tuberculin, and Candida albicans) activated a recall response from peripheral blood CD4 1 T cells. 11 The bulk antigen used precluded an evaluation of antigen specificity of the CD4 1 T-cell response. In another study IFN-g-stimulated human CD133
-derived MCs established synapses with CD4
1 T cells in vitro through superantigen and in situ in psoriatic skin, driving CD4 1 T cells toward concomitant production of IL-22 and IFN-g or IL-17. 12 Neither of these studies directly addressed the ability of MCs to take up and process antigen.
This study uses in situ-matured primary human MCs and CD4
1 T cells to diligently assess the ability of MCs to act as APCs. Our data confirm the key role of IFN-g in induction of HLA class II, HLA-DM, CD80, and CD40 expression on MCs and proceeds to evaluate the mechanism or mechanisms by which MCs take up, process, and present natural antigen to CD4 1 T cells. Our results indicate that human MCs are unique APCs.
METHODS
A full description of the methods used in this study is available in the Methods section in this article's Online Repository at www.jacionline.org.
Human subjects
Human tissues were obtained as approved by the Human Studies Internal Review Board at Virginia Commonwealth University (VCU). Tissues and written informed consent forms were obtained by the VCU Tissue and Data Acquisition and Analysis Core Facility, Cooperative Human Tissue Network (http://www.chtn.nci.nih.gov/), and Richmond Plastic Surgeons (Richmond, Va).
MC isolation and culture
MC isolation from human skin was performed, as previously described. 13 Briefly, MCs were dispersed from the skin, enriched, and then cultured in X-VIVO 15 medium (Lonza, Walkersville, Md) containing recombinant human stem cell factor (100 ng/mL; Swedish Orphan Biovitrum, Stockholm, Sweden). Without other cytokines or serum, non-MC populations do not survive, leaving MCs of greater than 98% purity after approximately 3 weeks.
MC surface protein expression
APC-related surface molecule expression was analyzed by using flow cytometry (see the Methods section in this article's Online Repository). For DEC-205 analysis, cells were labeled with anti-DEC-205 antibody at 48C and then warmed to 378C to facilitate receptor internalization.
MC degranulation
MCs were incubated with an FcεRIa-aggregating IgG (22E7, 100 ng/mL) to induce degranulation and assessed by means of measurement of mature tryptase with an ELISA, as previously described. 14 
T-cell isolation and storage
Jurkat cells were a gift from Dr David Straus (VCU). Human CD4 1 T cells were isolated from peripheral blood by using the RosetteSep CD4 1 T-cell negative selection kit, according to the manufacturer's instructions (STEMCELL Technologies, Vancouver, British Columbia, Canada), and then cryopreserved in serum-free freezing media (ATCC, Manassas, Va).
MC-Jurkat cell cocultures
Bacterial superantigen staphylococcal enterotoxin E (SEE) binds Jurkat cell Vb8-containing T-cell receptors, whereas toxic shock syndrome toxin 1 (TSST) cannot. 15 Mast cells primed with IFN-g (MC 
MC-CD4
1 T-cell cocultures Ø s were incubated on ice or at 378C with or without opsonization with pooled human IgG or rabbit polyclonal anti-S aureus IgG.
MC endocytosis was inhibited with 5-(N,N-dimethyl) amiloride hydrochloride (DMA; Sigma-Aldrich), Dynasore (EMD Millipore, Billerica, Mass), or both or vehicle control dimethyl sulfoxide (Sigma-Aldrich). MCs were incubated with inhibitors for 30 minutes and then with antigen for 2 hours and then analyzed. Viability was determined by using trypan blue exclusion (Sigma-Aldrich).
For colocalization analysis, MC g s and MC Ø s were incubated with or without DQ-OVA (5 mg/mL) for 2 or 8 hours. Cells were then fixed, permeabilized, and labeled with anti-HLA-DR, anti-tryptase, and DQ-OVA signal amplifying anti-BODIPY FL antibodies. Images acquired by using LSM 710 laser scanning confocal microscopy (Carl Zeiss Microscopy, Thornwood, NY) and N-SIM structured illumination microscopy (Nikon Instruments, Melville, NY) were analyzed by using the Coloc2 plugin within the Fiji build of ImageJ (available at http://fiji.sc).
MC presentation of cytomegalovirus

MCs and CD4
1 T cells were prepared from the same donor. Inactivated lysates of human cytomegalovirus (CMV)-and mock-infected foreskin fibroblasts (Advanced Biotechnologie, Columbia, Md) were added to MCs for 3 days; IFN-g was added for the last 2 days. MCs were then cocultured with CFSE-labeled T cells (1:2 ratio) for 7 days.
For certain experiments, MCs were incubated for 30 minutes with endocytosis inhibitors before addition of lysates for 6 hours, washed (preserving viability), and then incubated with IFN-g for 2 days. In others, CMV-and IFN-g-primed MCs were stimulated for 30 minutes with 22E7 (100 ng/mL) or isotype control, washed, incubated in fresh medium for 2 hours to allow for residual granule release, washed again, and then cocultured with T cells.
Statistics
Parametric or nonparametric statistical tests were used as appropriate (see the Methods section in this article's Online Repository).
RESULTS
Primary human MCs require IFN-g to express HLA class II At baseline, MCs express the IFN-g receptor CD119 (see Fig  E1, A, in this article's Online Repository at www.jacionline. org). Treatment with IFN-g led to an increase in CD64 levels on MCs, which is consistent with previous reports, but did not affect FcεRI expression, granule contents, or the ability to degranulate (see Fig E1, B-F) . Induction of surface HLA-DR expression by IFN-g (Fig 1, A and B ) was significant after 2 days (see Fig E2, A, in this article's Online Repository at www. jacionline.org) and was augmented by heat-killed Listeria monocytogenes (Fig 1, C) but not by IL-4 or Toll-like receptor 4 or 9 agonists (see Fig E2, B) . A superantigen-based assay of Jurkat 12-myristate 13-acetate (PMA; n 5 3; mean 6 SD). E-G, Surface CD80 (Fig 1, E ; n 5 14), CD40 (Fig 1, F ; n 5 15), and CD86 (Fig 1, G ; n 5 6) expression after incubation with or without IFN-g. Fig 1, B and D-G, ***P < .001. MFI, Geometric mean fluorescence intensity; ns, not significant. (Fig 1, D) . Moreover, Jurkat cell activation required physical contact with MC Receptor-ligand interactions between CD40/CD40 ligand, CD80/CD28, and CD86/CD28 (APC/T cell, respectively) enhance immune synapse formation and cross-activation. [16] [17] [18] [19] [20] [21] [22] IFN-g augmented by heat-killed Listeria monocytogenes increases MC expression of CD80 and CD40 (Fig 1, E and F, and see Fig E2, C) . Such MCs did not express CD86 (Fig 1, G) .
A subset of human peripheral blood CD4 1 T cells produce IFN-g. 23 Indeed, surface HLA class II expression on MC Ø s occurred after a 4-day coculture with such polyclonal T cells (Fig 2, A) . Inhibition by IFN-g-neutralizing antibodies (aIFN-g), IFN-g receptor (IFN-gR)-blocking antibodies (aIFNgR), or both in TSST-stimulated cocultures reduced T-cell proliferation in MC Ø -T-cells but not MC g -T-cell cocultures. aIFNgR was more effective than aIFN-g, perhaps because IFN-g secreted by T cells at a synapse during coculture is physically protected from neutralizing antibodies, whereas aIFNgR blocks the receptor before synapse formation (Fig 2, B and C).
Human T H 1 T cells identified based on CXCR3 surface expression are a major source of IFN-g. CD4
1 T cells were sorted into CXCR3
1 and CXCR3 2 populations (Fig 2, D) before (Fig 2, F) . Altogether, these data indicate that IFN-g produced by T H 1 T cells is sufficient to upregulate MC HLA class II expression and, in the presence of TSST, initiates a feedforward loop that induces T-cell proliferation.
MCs process antigens without requiring IFN-g or opsonization
The ability to process antigen is a key feature of APCs. MC Ø internalization of DQ-OVA or DQ-BSA was time and concentration dependent (Fig 3, A) , as measured by means of proteolysis-mediated fluorescence. IFN-g is a maturation factor for dendritic cells (DCs) that decreases antigen internalization, 24 -26 yet coupled uptake and proteolysis of DQ-OVA was similar between MC g s and MC Ø s (Fig 3, B) . Both MC g s and MC Ø s also efficiently internalized the particulate antigen BP (Fig 3, C) .
IFN-g induces MC expression of FcgRI (CD64). 27 BPs were opsonized with either pooled human IgG-or rabbit anti-S aureus observed, implying that a larger portion of BPs was bound to the cell surface and not internalized (Fig 3, D) . This might be due to increased expression of CD64, although the overall effect was small. Expression of known endocytic receptors was evaluated on MCs. MCs lack mRNA or protein expression of many endocytic receptors, including dendritic cell immunoreceptor, dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin, Dectin-1/2, and mannose receptor, C-type 1 (see Fig E4 and Table E1 in this article's Online Repository at www. jacionline.org). MCs expressed the endocytic receptor DEC-205 (Fig 3, E , and see Table E1 ). 28 MCs were incubated with an anti-DEC-205 antibody that triggered internalization (Fig 3, E and F), beginning at 2 minutes and reaching a plateau by approximately 10 minutes. Because IFN-g enhances DEC-205 expression (Fig 3, E) without affecting the percentage of receptors internalized, the absolute number of internalized receptors per cell significantly increased for MC g s over MC Ø s from 2 to 20 minutes (Fig 3, G) . This implies that IFN-g enhances DEC-205-dependent antigen internalization.
Overall, MCs take up and process both soluble and particulate antigens in an IgG opsonization-and IFN-g-independent manner and express functional DEC-205.
MCs induce a CMV-specific CD4
1 T-cell response CMV is a natural and robust model to study human T-cell responses because previously infected human subjects have a high burden of CMV-responsive T cells. 29, 30 Inactivated lysates of CMV-infected and mock-infected foreskin fibroblasts were used in donor-matched ex vivo MC/CD4
1 T-cell cocultures to assess the ability of MCs to process and present natural antigen (Fig 4, C) , IL-4 (Fig 4, D) , or IL-17 (Fig 4, E) . . Fig 4, B-E, *P < .05, **P < .01, and ***P < .001. ns, Not significant.
(see Fig E5, A, in this article's Online Repository at www. jacionline.org). CD4 1 T-cell proliferation (percentage of CD25 high CFSE low cells) was not detected when CMV lysate was added to CD4 1 T cells from seropositive or seronegative subjects (Fig 4, A, CD4 1 T1CMV), indicating a lack of contaminating APCs. In contrast, robust T-cell proliferation occurred when T cells from seropositive or seronegative subjects were cocultured with MCs and TSST (Fig 4, A, MC1TSST ). T-cell proliferation was negligible in MC-T-cell cocultures from seronegative subjects, regardless of antigen or IFN-g exposure (Fig 4, A and B) . ), T-cell activation was substantially higher (Fig 4, A) . Composite data from multiple seropositive sources show significant increases in percentages of proliferating T cells in CMV9MC Ø -T-cell and CMV9MC g -T-cell cocultures compared with their respective controls, Mock9MC Ø -T cells and Mock9MC g -T cells (Fig 4,  B) , although a difference between CMV9MC Ø s and CMV9MC g s was inconsistent. This might be due in part to donor-to-donor differences in an antigen-specific outbred model, which include numbers of both IFN-g 1 T H 1-and CMV-specific T cells. The T-cell response from seropositive but not seronegative subjects indicates that this is primarily a recall response. CD4 1 T-cell cytokine production was evaluated after a 4-hour incubation with brefeldin A to inhibit secretion on the last day of coculture. The median percentage of T H 1 cells of proliferating T cells from CMV9MC Ø -T-cell or CMV9MC
g -T-cell cocultures dramatically increased (Fig 4, C) , whereas the percentage of T H 2 cells was unchanged (Fig 4, D) , and the percentage of T H 17 cells modestly decreased (Fig 4, E) . Overall, these data indicate that MCs function as APCs to induce a CMVappropriate T H 1 cell response.
MCs take up CMV protein in a dynamin-dependent manner
MCs express a limited repertoire of endocytic receptors but exhibit robust antigen uptake. Uptake inhibitors were used to explore the pathway or pathways through which MCs internalize antigen. Both Dynasore, which inhibits dynamin-mediated clathrin-and caveolin-dependent endocytosis, and DMA, which inhibits phagocytosis and micropinocytosis, inhibited MC DQ-OVA endocytosis with an inhibitory concentration of 50% of approximately 200 mmol/L (Fig 5, A and B) . Unexpectedly, low concentrations of Dynasore increased DQ-OVA uptake, perhaps because of cell-specific off-target effects. Inhibition by combined DMA and Dynasore was additive, resulting in near-total inhibition of DQ-OVA uptake at 200 mmol/L of both (Fig 5, C  and D) . Neither drug, either used alone or in combination, decreased cell viability at the concentrations tested (see Fig E6, A-D, in this article's Online Repository at www.jacionline.org).
Dextran and BP uptake resembled that of DQ-OVA in its response to DMA or Dynasore inhibition (see Fig E6, E and F) , but DQ-BSA uptake was only inhibited in the presence of combined agents (Fig 5, E) , perhaps because BSA is less 5, A) or DMA (Fig 5, B) . C and D, Uptake of DQ-OVA by MCs pretreated with both DMA and Dynasore or DMSO at various concentrations. E, DQ-BSA uptake by MC MCs were pretreated as in Fig 5, E, before priming with CMV. Fig 5, A, B , and E, Paired t test, mean 6 SD. Fig  5, F, Repeated-measures ANOVA with Tukey' test. Fig 5, A-F, Net mean fluorescence intensity (MFI) was normalized to control values (n 5 4). *P < .05, **P < .01, and ***P < .001. ns, Not significant.
glycosylated than ovalbumin and reportedly uses different uptake pathways. 31 For all antigens tested, there were no differences in uptake inhibition between MC g s and MC Ø s. To evaluate mechanisms for CMV antigen uptake, MCs were treated with Dynasore, DMA, or both and then primed with CMV and cocultured with donor-matched CD4 1 T cells (see Fig E5, B) . Dynasore, but not DMA, significantly reduced the T-cell proliferative response, and combining these inhibitors yielded no additional inhibition (Fig 5, F) . Overall, MCs take up DQ-OVA and BPs through a variety of mechanisms, whereas CMV antigen uptake occurs through dynamin-dependent endocytosis but not through phagocytosis or micropinocytosis.
MC
g antigen-presenting machinery transiently colocalizes to secretory granules Human MCs produce a unique array of proteases that are stored together inside secretory granules. 32, 33 Treatment with IFN-g caused no change in the tryptase distribution during confocal imaging. In MC Ø s DQ-OVA colocalizes with tryptase, whereas HLA-DR is essentially absent. In MC g s HLA-DR is readily identified and colocalizes with both antigen and tryptase (Fig 6, A) . Colocalization analysis was performed on images of MC g s obtained by using structured illumination microscopy after DQ-OVA exposure for 2 or 8 hours to more precisely examine the location of antigen, HLA-DR, and tryptase. Overlap between antigen and HLA-DR was stable, whereas tryptase overlapped antigen or HLA-DR to a greater extent at 2 than 8 hours (Fig 6,  A , and see Fig E7, A-C, in this article's Online Repository at www.jacionline.org). This suggests that antigen and HLA-DR transiently move into and then out of granules containing tryptase.
To explore this co-opting of MC secretory granules, we assessed surface CD63 and HLA-DM expression after degranulation. Granule membrane CD63 is transported to the cell surface upon MC degranulation. 34 In DCs, HLA-DM localizes to lysosomal structures containing HLA class II-peptide complexes. 35, 36 At 1 minute after addition of IgG anti-FcεRI, HLA-DM expression is higher on the surfaces of CD63 hi than CD63 lo MCs, corresponding to early degranulated MCs (Fig 6,  B) . Surface HLA-DM expression significantly increased in the CD63 hi MCs at 1, 10, and 60 minutes after degranulation, returning to baseline by 240 minutes (Fig 6, C) .
Unlike HLA-DM, surface HLA-DR expression increases continuously over several days after a single bolus of IFN-g (see Fig E1, B) . When MCs were IFN-g stimulated for only 18 hours to exaggerate the contribution of degranulationmediated transport over constitutive transport, MC g s, but not MC Ø s, showed a significant but modest increase in surface HLA-DR expression after degranulation (Fig 6, D) . The consequences of such an increase were evaluated in donor-matched MC-T-cell cocultures. Anti-FcεRI-stimulated CMV9MC g s, but not CMV9MC Ø s, induced significantly higher T-cell proliferation compared with control cells, as measured by using the ModFitLT proliferation index (Fig 6, E) .
Supernatants from donor-matched cocultures in Fig 4 were evaluated for granule release to evaluate the significance of co-opted secretory granules apart from IgE receptor activation. In the absence of T cells, neither CMV lysate nor TSST induced release of mature tryptase from MCs (see Fig E7, D and E) , a sensitive indicator of degranulation. 
DISCUSSION
We find that IFN-g induces expression of HLA-DR, HLA-DM, CD80, and CD40 on primary human MCs. At baseline or after IFN-g priming, MCs also take up both soluble and particulate antigens through micropinocytosis, phagocytosis, and endocytosis. MCs combine these characteristics to induce an antigen-specific recall response of CD4
1 T H 1 cells, raising the possibility that their antigen-presenting capability contributes to processes of health and disease. Importantly, there are ample opportunities for MCs to encounter IFN-g in vivo. [37] [38] [39] [40] [41] Notably, this is the first study to show that MCs transiently co-opt their secretory granules for antigen processing and presentation. The unique array of proteases in MC secretory granules, including cathepsins, found in many cell types, along with tryptase, chymase, and carboxypeptidase A3 selectively expressed by MCs, raises the possibility that MCs produce and present a distinct peptide repertoire. Indeed, a cursory in silico analysis showed that MC chymase could generate peptides from the CMV pp65 protein that are predicted to effectively bind HLA-DR alleles (data not shown). Although a more extensive inquiry is beyond the scope of the current study, this concept clearly merits further investigation.
Our study has several limitations. Peripheral blood CD4
1
T cells likely include mostly memory and some naive cells, but the response to CMV9MCs almost certainly represents a recall response because T cells from CMV-seronegative subjects did not respond. Although IFN-g-primed MCs are capable of antigen uptake, processing, and presentation to T H 1 cells, we did not address the ability of MCs to activate naive CD4 1 T cells or to elicit a recall response from T H 2 or T H 17 T cells. In addition, our in vitro model precludes an assessment of whether MC encounters with T cells occur in vivo in draining lymph nodes 42 or in organ-associated tertiary lymphoid structures, 43 which would require migration of MCs to those sites, or in the tissues where MCs normally reside. Thus our findings do not fulfill all characteristics of professional APCs. Accordingly, we speculate that MCs act as APCs at local sites, serving to modulate acute, chronic, and recurrent recall responses to antigens.
An atypical aspect of MCs as APCs is their failure to express CD86. CD86 is constitutively expressed in low amounts on DCs, whereas CD80 has higher affinity for both CD28 and cytotoxic T lymphocyte-associated antigen 4, in part because of its oligomeric surface expression. [44] [45] [46] Whereas most in vitro data do not distinguish functional differences between the 2 ligands, 2 areas of in vivo inquiry have been fruitful. First, CD80 appears to make a more significant contribution to cytotoxic T-cell activation 47 and delayed-type hypersensitivity responses. 48 Second, CD80 makes a stronger contribution to the expansion of inducible and natural regulatory T cells. 49, 50 Although these findings might seem contradictory, it is important to note that the function of CD80 is dependent on the timing and degree of surface expression of CD28, cytotoxic T lymphocyte-associated antigen 4, and even the B7 family member programmed cell death ligand 1 on T cells. 51, 52 Human MCs represent a unique opportunity to dissect CD80 contributions to T-cell phenotypes in vitro.
MC antigen uptake appears to occur independently from IFN-g priming and is associated with a limited repertoire of uptake receptors, including DEC-205. DEC-205-targeted antigen results in a dramatic enhancement of antigen presentation by DCs. 28, 53 DEC-205 natural ligands reportedly include a receptor for class B CpG oligonucleotides, oxidized low-density lipoproteins, HIV gag protein, and apoptotic and necrotic cells. [54] [55] [56] [57] The DEC-205 ligand or ligands in the CMV lysate used in this study have not been characterized. Because DEC-205 function is dynamin sensitive, as is MC presentation of CMV antigen, DEC-205 might contribute to CMV uptake by MCs. Although direct assessment of DEC-205 function was beyond the scope of the current study, future work should evaluate the contribution of DEC-205 to MC APC function.
Our findings support a growing literature that highlights the abilities of MCs to extend beyond an isolated allergen-IgE-FcεRI axis. In patients with chronic atopic dermatitis, expression of IFN-g is well described, 37 and MC-mediated activation of T cells through superantigens from S aureus in overcolonized skin might contribute to pathogenesis. Severe steroid-resistant asthma is linked to increased IFN-g levels in human airways, and an IFN-g-MC axis of inflammation has been identified in mouse models of chronic asthma. 40, 41 Indeed, in the context of human disease, inflammation is rarely a pure T H 1, T H 2, or T H 17 phenomenon, and the relationship between MC degranulation and enhanced MHC class II expression might represent a special form of crosstalk between MCs and T cells.
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Key messages
d IFN-g induces human MC expression of HLA-DR, CD80, CD40, and HLA-DM and co-opts secretory granules for antigen processing and presentation.
d IFN-g-primed MCs induce a superantigen-specific T-cell response.
d IFN-g-primed MCs induce a CMV-specific T H 1 T-cell recall response.
MC mRNA expression
Baseline total mRNA prepared from skin MCs was analyzed by using Human Genome U133 Set GeneChip arrays (Affymetrix, Santa Clara, Calif), according to the manufacturer's instructions. Expression data were analyzed with the Expression Console software package (Affymetrix) using the MAS5 algorithm. T-cell studies 
Flow cytometry
MC antigen uptake
DQ-OVA (Life Technologies) and DQ-BSA (Life Technologies) were supplied overlabeled with the fluorescent dye BODIPY-FL, such that selfquenching among adjacent fluorophore molecules rendered the intact antigen essentially nonfluorescent. Proteolysis within endosomes terminates the selfquenching, resulting in increased fluorescence. MCs were incubated for various lengths of time with various concentrations of DQ-OVA and DQ-BSA in MC Medium at 378C. Cells were then washed in ice-cold FACS buffer, and fluorescence was measured by means of flow cytometry with the FITC filter set. MCs were incubated with DQ-OVA (5 mg/mL) or unlabeled OVA (5 mg/ mL, Sigma-Aldrich) for 2 hours at 378C to exclude a change in autofluorescence caused by protein uptake. Cells were then washed thoroughly in icecold FACS buffer and analyzed by using flow cytometry (Fig E3, A) .
Dye quenching is less effective for glucan and particulate antigens, and therefore a pH-sensitive dye was used to indicate uptake of these antigens into acidic endosomes or secretory granules. MCs were incubated with pHrodo-green dextran (Life Technologies) for various lengths of time at various concentrations in MC Medium at 378C, washed in ice-cold FACS buffer, and analyzed for fluorescence by using flow cytometry with the FITC filter set. In other experiments pHrodo-labeled S aureus BPs (Life Technologies) were suspended in Hank balanced salt solution at 1 mg/mL. Aliquots of BPs were then opsonized by means of incubation at 378C for 1 hour with either pooled human IgG (125 mg/mL, Sigma-Aldrich) or rabbit polyclonal anti-S aureus IgG (125 mL/mg BPs; BioParticles Opsonizing Reagent, Life Technologies), followed by thorough washing. MCs were then incubated with or without BPs that had been opsonized or not opsonized for 1 hour at 378C or on ice. MCs were washed to remove free BPs, and then fluorescence was measured by using flow cytometry with a PE filter set. Percentage of internalization was calculated by using the following formula: 100 3 ([Fluorescence at 378C with BP 2 Fluorescence on ice with BP]/[Fluorescence at 378C with BP 2 Fluorescence on ice without BP]).
In silico MHC binding analysis
As a proof of concept, potential peptide fragments of the CMV pp65 protein were generated by using the reported substrate specificity preferences of human chymase. E1,E2 A single candidate peptide (LEVQAIRETVELR-QYDPVAALF) was selected based on an approximate length known to fit into the MHC class II binding grove. Binding to the HLA-DRB1*01 allele was predicted by using the Immune Epitope Database (available at http:// www.iedb.org).
Statistics
All data were assessed by using the Shapiro-Wilks test for normal distribution. Thereafter, the appropriate parametric or nonparametric statistical test was used. If the same MC source was assessed in multiple conditions, paired tests were used. Data were analyzed with SigmaPlot (Systat, San Jose, Calif) and SPSS Statistics (IBM, Armonk, NY) software. The CFSE proliferation index was calculated with ModFit LT (Verity, Topsham, Me). A-G, Signed rank test: *P < .05 and **P < .01. 
